BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«Tablets

Below is an extended Tablets news listing. Click here to return to the Tablets main in depth entry.

BioNews Results for Tablets:

NovaDel Announces Data from Pilot Efficacy Study Comparing Sumatriptan Oral Spray to Imitrex Tablets
Pharma Live:  Sep 5 2008 3:22PM Matching: tablets
NovaDel Announces Data from Pilot Efficacy Study Comparing Sumatriptan Oral Spray to Imitrex(R) Tablets
SmartBrief:  Sep 5 2008 2:43PM Matching: tablets
NovaDel Announces Data from Pilot Efficacy Study Comparing Sumatriptan Oral Spray to Imitrex Tablets
Therapeutics Daily:  Sep 5 2008 12:53PM Matching: tablets
QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal
KRON4:  Sep 5 2008 6:09AM Matching: tablets
Biovail Announces Filing of ANDA for Fenofibrate Tablets
PipelineReview:  Sep 5 2008 12:56AM Matching: tablets
QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) In Women With Postmenopausal Vaginal
PipelineReview:  Sep 5 2008 12:56AM Matching: tablets
NovaDel Announces Data from Pilot Efficacy Study Comparing Sumatriptan Oral Spray to Imitrex(R) Tablets
PipelineReview:  Sep 5 2008 12:55AM Matching: tablets
QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal
KOTA Territory News:  Sep 4 2008 11:04PM Matching: tablets
FDA Announces HIV/AIDS Update
Pharma Live:  Sep 4 2008 5:03PM Matching: tablets
QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal
NewsBlaze:  Sep 4 2008 3:43PM Matching: tablets
QuatRx Initiates Second Phase 3 Study of Ophena (Ospemifene Tablets) in Women With Postmenopausal Vaginal Synd
Pharma Live:  Sep 4 2008 3:03PM Matching: tablets
NovaDel Pharma reveals Data from Pilot Efficacy Study Comparing Sumatriptan Oral Spray to Imitrex Tablets - Qu
RTTNews.com:  Sep 4 2008 1:24PM Matching: tablets
Filing of ANDA for Fenofibrate Tablets
Therapeutics Daily:  Sep 4 2008 1:06PM Matching: tablets
Biovail Announces Filing of ANDA for Fenofibrate Tablets
DiGiTAL50:  Sep 4 2008 6:33AM Matching: tablets
Biovail Announces Filing of ANDA for Fenofibrate Tablets
Red Orbit:  Sep 4 2008 5:49AM Matching: tablets
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional